Genzyme Corp. (Nasdaq: GENZ) announced the withdrawal of the European application to extend the Evoltra® (clofarabine) product label to include the treatment of elderly patients with acute myeloid le
read more » Discuss Add this link to...Bury Add to:
| Bookmarks